493
Participants
Start Date
July 3, 2019
Primary Completion Date
July 26, 2021
Study Completion Date
July 26, 2021
Brolucizumab 6 mg
Solution for injection (intravitreal use)
Aflibercept 2 mg
Solution for injection (Intravitreal use)
Sham injection
Empty sterile syringe without a needle administered as a sham injection for masking. From Week 24 to Week 72 inclusive, a sham treatment was performed to maintain subject masking in case treatment with brolucizumab or aflibercept was not deemed necessary by the investigator.
Novartis Investigative Site, Budapest
Novartis Investigative Site, Sydney
Novartis Investigative Site, Strathfield
Novartis Investigative Site, Parramatta
Novartis Investigative Site, Albury
Novartis Investigative Site, Melbourne
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Nedlands
Novartis Investigative Site, Hobart
Novartis Investigative Site, Pécs
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Prague
Novartis Investigative Site, Monroeville
Novartis Investigative Site, Donostia / San Sebastian
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Dijon
Novartis Investigative Site, Madrid
Novartis Investigative Site, Charlotte
Novartis Investigative Site, Hanover
Novartis Investigative Site, St. Petersburg
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Nashville
Novartis Investigative Site, Memphis
Novartis Investigative Site, Shah Alam
Novartis Investigative Site, Khon Kaen
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Nantes
Novartis Investigative Site, Cleveland
Novartis Investigative Site, Cleveland
Novartis Investigative Site, Valencia
Novartis Investigative Site, Indianapolis
Novartis Investigative Site, New Albany
Novartis Investigative Site, Münster
Novartis Investigative Site, Zaragoza
Novartis Investigative Site, Mainz
Novartis Investigative Site, Minneapolis
Novartis Investigative Site, Leawood
Novartis Investigative Site, Lenexa
Novartis Investigative Site, Batu Caves
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Bari
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Arlington
Novartis Investigative Site, Houston
Novartis Investigative Site, Houston
Novartis Investigative Site, Bellaire
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Austin
Novartis Investigative Site, Austin
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Abilene
Novartis Investigative Site, Colorado Springs
Novartis Investigative Site, Phoenix
Novartis Investigative Site, Ulm
Novartis Investigative Site, Reno
Novartis Investigative Site, Songkhla
Novartis Investigative Site, La Jolla
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Santa Barbara
Novartis Investigative Site, Créteil
Novartis Investigative Site, Mountain View
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Harbin
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Wuxi
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Wenzhou
Novartis Investigative Site, Chongqing
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Cheboksary
Novartis Investigative Site, Wuhan
Novartis Investigative Site, Guangzhou
Novartis Investigative Site, Shantou
Novartis Investigative Site, Chengdu
Novartis Investigative Site, Yekaterinburg
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Tel Aviv
Novartis Investigative Site, Rehovot
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Fort Myers
Novartis Investigative Site, Stoneham
Novartis Investigative Site, Bloomfield
Novartis Investigative Site, Madison
Novartis Investigative Site, Calgary
Novartis Investigative Site, London
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Québec
Novartis Investigative Site, Hradec Králové
Novartis Investigative Site, Pardubice
Novartis Investigative Site, Prague
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Heraklion Crete
Novartis Investigative Site, Larissa
Novartis Investigative Site, Szeged
Novartis Investigative Site, Nagakute
Novartis Investigative Site, Kōriyama
Novartis Investigative Site, Kita-gun
Novartis Investigative Site, Tsu
Novartis Investigative Site, Matsumoto
Novartis Investigative Site, Nagasaki
Novartis Investigative Site, Chiyoda-ku
Novartis Investigative Site, Hachiōji
Novartis Investigative Site, Taito-ku
Novartis Investigative Site, Tilburg
Novartis Investigative Site, Arecibo
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Ankara
Novartis Investigative Site, Bury Saint Edmonds
Novartis Investigative Site, Leeds
Novartis Investigative Site, Liverpool
Novartis Investigative Site, London
Novartis Investigative Site, Newcastle upon Tyne
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY